Silco Pharmaceutical Limited IPO Lottery Result published on 10 April 2019 & found here. Silco Pharmaceutical Limited Subscription Open from March 07, 2019, and Close on March 19, 2019. Silco Pharmaceutical Limited IPO Lottery Result updated. Download Silco Pharmaceutical Limited IPO Lottery Result that will be published & found here. IPO or an Initial Public Offer (IPO) is the first sale of a stock by a private company to the public company. In this way, a company can increase money by issuing either debt or equity. IPO or Share market inauguration is a type of public offer in which shares of a company generally are sold to the predictable investors that in turn, sell to the general public by a securities exchange for the first time.
SILCO Pharmaceutical Limited IPO Lottery Result & Information
In this way, a private company converts into a public limited company. IPOs are often issued by smaller or newer companies seeking the funds or capital to expand, but can also be done by large privately-owned companies looking to become in public trading.
Download Prospectus of Silco Pharmaceutical Limited
Initial Public Offer (IPO) of SILCO Pharmaceutical Limited
Silco Pharmaceutical Ltd IPO Lottery Result found here. Bangladesh Securities and Exchange Commission (BSEC) has approved the initial public offering (IPO) of Silco Pharmaceutical Limited on 28 November 2018 at their 668 no. board meeting. A BSEC meeting, presided over by its chairman M Khairul Hossain, approved the IPO proposal of Silco Pharmaceutical Limited, said a BSEC press release. BSEC approved the IPO of the company to raise capital of Tk 30 crore from the market by offering 3 crore shares at a price of Tk. 10 each share under the Fixed Price method.
According to the Financial Statement The company’s earnings per share (EPS) was Tk 1.64 and the net asset value (NAV) per share Tk 27.05 at the end of June 30, 2018. EBL Investments Limited, City Bank Capital Resources Limited & Citizen Securities & Investment Limited have acted on behalf of the company’s issue manager. The company’s IPO fund will be used for Construction of new factory building in the existing vacant area, Import of new Machinery, Purchase of Delivery Van and meeting IPO expenses & IPO related other relevant expenses according to the IPO prospectus.
Silco Pharmaceutical Limited IPO Lottery Result Found Here
Silco Pharmaceutical Ltd IPO Lottery Result 2019 published on 10 April 2019 & found here. Download Silco Pharmaceutical Ltd IPO Lottery Result from here. After ending of application of Initial Public Offer (IPO) from 07 March to 19 March 2019. New Line Clothing Ltd IPO Lottery draw will be held on 10 April 2019. Place: Engineering Institute, IEB Millaniton, Ramna Dhaka at 10:30 A.M. The IPO results will be published on the websites of Dhaka Stock Exchange (DSE), Chittagong Stock Exchange (CSE) and the company’s website after the lottery programmed. See the Result below.
Click the following Link to get Silco Pharmaceutical LTD IPO Lottery Result
- Stock Broker/Merchant Bank Code
- General Public/Resident Bangladesh
- Non-Residence Bangladesh(NRB)
- Affected Small Investors
- All Eligible Investor (Pro-Data Allotment)
You can also get the result from the official website of Silco Pharmaceutical Limited IPO Lottery Result i.e. www.silcopharma.com
You can also download Silco PharmaceuticalLimited IPO Lottery Result from Dhaka Stock Exchange (DSE) original website http://www.dsebd.org/ipo_lottery_result.php
Silco Pharmaceutical Limited as per Prospectus
SILCO PHARMACEUTICALS LIMITED
(Subscription Open: March 07, 2019, Close: March 19, 2019)
Share Value: Taka 10/Per Share
Lot Distribution: 500
Premium Value: Taka 0/Per Share
Total Value Taka = 5,000/Lot
Issue Manager: EBL Investments Limited, City Bank Capital Resources Limited & Citizen Securities & Investment Limited have acted on behalf of the company’s issue manager.
Website: www.silcopharma.com
Click here to Download Prospectus of SILCO Pharmaceutical Limited
Brief Description with Address of SILCO Pharmaceutical Limited
Silco Pharmaceuticals Limited, the fastest growing pharmaceutical companies in Bangladesh since 1997 and is now on its way to becoming a high-performance global player. Our objectives are to conduct transparent business operation based on market mechanism within the legal & social framework with aims to attain the mission reflected by our vision.
The plant is situated at BSCIC Industrial Estate, Khadimnagor, Sylhet, Bangladesh (10KM East of Sylhet Zero Point on Sylhet Jaflong Road). The plant was set up in January 1996 having an area of approximately 45000 SFT of land.
SILCO Pharmaceutical started their journey taking along 10 products. Now we manufacture 108 products. In each year, Silco is introducing more than 10-20 new products. Our company attained ISO 9001:2015 certificate as a recognition to its Quality Management System
The manufacturing site is spread across a 45000 SFT area located in the BSCIC Industrial Estate,Khadimnagor,Sylhet, which houses facilities for manufacturing tablets, capsules, syrups, suspensions etc. It manufactures medicines of wide range of therapeutic classes like antiulcerants, antibiotics, NSAIDs, antipyretics, vitamins & minerals, laxatives, antidiabetics, antihypertensive & antianginal, antispasmodics, antihistamines, antipsychotics, antiemetics, etc. in this plant.
The site has its own utility infrastructure to ensure adequate generation and distribution of electricity with an installed capacity of 11 MW, besides having water purifying facilities. SILCO Pharmaceutical manufacturing facilities are routinely inspected by various health authorities around the Bangladesh.
To maintain quality standards, our plant has well defined procedures and systems in place in compliance with the requirements of the Current Good Manufacturing Practices (cGMP), WHO, in order to ensure that our operating procedures meet the standards of regulators like WHO. Each site has well trained personnel for quality control along with a regulatory affairs department ensuring strict adherence to quality systems and procedures.
The Bangladesh Securities and Exchange Commission (BSEC) has approved the initial publication of SILCO Pharmaceutical Limited (IPO) for withdrawing money from the stock exchange. This approval has been given in a regular meeting of the Commission.
Principal Products: Principal Products & Services are:
SILCO Pharmaceutical Ltd has been emerging of pharmaceuticals products. Silco Pharmaceuticals limited has engaged in manufacturing and marketing of pharmaceuticals finished product in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Antipyretics, Anti Inflammatory Drugs, Antiulcer ants, Multi medicines which are sold in local market. It has set up a modern pharmaceutical plant that is equipped with advanced and modern machineries and technologies.
The Company has following principal products:
1. Tablet 2. Capsules; 3. Liquid Syrup; 4. Dry Syrup; 5. Pellet; 6. Powder; 7.Powder Suspension; 8. SRS Saline
Name of Subsidiaries:
There is no subsidiaries of SILCO Pharmaceutical Ltd.
Registered Office
Registered & Corporate Office
41, Nurani, Bankalapara, Subid Bazar, Sylhet-3100,
Factory: BSCIC Industrial Estate, Khadimnagor, Sylhet-3103
Phone: +88 0821-722241, 0821-728512
Fax: Nil
E-mail: info@silcopharma.com
Corporate Head Office
Registered & Corporate Office
41, Nurani, Bankalapara, Subid Bazar, Sylhet-3100,
Factory: BSCIC Industrial Estate, Khadimnagor, Sylhet-3103
Phone: +88 0821-722241, 0821-728512
Fax: Nil
E-mail: info@silcopharma.com
Web: www.silcopharma.com
You can also get the result of
IPO Latest Update Information Latest
You can also Like & follow our Facebook Fan Page, Twitter, Linkedin, Google+ and Facebook Group for more details information.
If you want to get the available information regarding “SILCO Pharmaceutical Limited IPO Lottery Result” please always stay and follow this site Common Target.
